These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33823951)

  • 1. International Psychogeriatric Association (IPA) consensus for defining psychosis in major and mild neurocognitive disorders.
    Sano M; Cummings J; Jeste DV; Finkel S; Reichman W
    Int Psychogeriatr; 2022 Mar; 34(3):203-207. PubMed ID: 33823951
    [No Abstract]   [Full Text] [Related]  

  • 2. Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition.
    Cummings J; Pinto LC; Cruz M; Fischer CE; Gerritsen DL; Grossberg GT; Hwang TJ; Ismail Z; Jeste DV; Koopmans R; Lanctot KL; Mateos R; Peschin S; Sampaio C; Tsuang D; Wang H; Zhong K; Bain LJ; Sano M
    Am J Geriatr Psychiatry; 2020 Dec; 28(12):1256-1269. PubMed ID: 32958332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition.
    Sano M; Cummings J; Auer S; Bergh S; Fischer CE; Gerritsen D; Grossberg G; Ismail Z; Lanctôt K; Lapid MI; Mintzer J; Palm R; Rosenberg PB; Splaine M; Zhong K; Zhu CW
    Int Psychogeriatr; 2024 Apr; 36(4):238-250. PubMed ID: 36880250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm.
    Cummings J; Sano M; Auer S; Bergh S; Fischer CE; Gerritsen D; Grossberg G; Ismail Z; Lanctôt K; Lapid MI; Mintzer J; Palm R; Rosenberg PB; Splaine M; Zhong K; Zhu CW
    Int Psychogeriatr; 2024 Apr; 36(4):251-262. PubMed ID: 36876335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis.
    Eisenacher S; Rausch F; Ainser F; Englisch S; Becker A; Mier D; Fenske S; Meyer-Lindenberg A; Kirsch P; Zink M
    Early Interv Psychiatry; 2018 Aug; 12(4):586-595. PubMed ID: 27169782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs).
    Cuesta MJ; Sánchez-Torres AM; Lorente-Omeñaca R; Zandio M; Moreno-Izco L; Peralta V
    Psychiatry Res; 2020 Nov; 293():113404. PubMed ID: 32911349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research.
    Fischer CE; Ismail Z; Youakim JM; Creese B; Kumar S; Nuñez N; Ryan Darby R; Di Vita A; D'Antonio F; de Lena C; McGeown WJ; Ramit R; Rasmussen J; Bell J; Wang H; Bruneau MA; Panegyres PK; Lanctôt KL; Agüera-Ortiz L; Lyketsos C; Cummings J; Jeste DV; Sano M; Devanand DP; Sweet RA; Ballard C
    J Alzheimers Dis; 2020; 73(3):1143-1156. PubMed ID: 31884469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis.
    Zheng W; Zhang QE; Cai DB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    J Psychiatr Res; 2018 Aug; 103():38-45. PubMed ID: 29772485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus.
    Kales HC; Lyketsos CG; Miller EM; Ballard C
    Int Psychogeriatr; 2019 Jan; 31(1):83-90. PubMed ID: 30068400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Publication of the International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia.
    Chiu E; Jeste D
    Curr Opin Psychiatry; 2007 Nov; 20(6):531-2. PubMed ID: 17921750
    [No Abstract]   [Full Text] [Related]  

  • 11. Geriatric psychosis.
    Lacro JP; Jeste DV
    Psychiatr Q; 1997; 68(3):247-60. PubMed ID: 9237319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of different models of care for nursing home residents with dementia complicated by depression or psychosis.
    Brodaty H; Draper BM; Millar J; Low LF; Lie D; Sharah S; Paton H
    J Clin Psychiatry; 2003 Jan; 64(1):63-72. PubMed ID: 12590626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2005 International Psychogeriatric Association (IPA) research awards in psychogeriatrics.
    Ames D
    Int Psychogeriatr; 2006 Mar; 18(1):1-2. PubMed ID: 16403250
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlates of psychotic symptoms among elderly outpatients.
    Holroyd S; Laurie S
    Int J Geriatr Psychiatry; 1999 May; 14(5):379-84. PubMed ID: 10389042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery.
    Kelleher I; Clarke MC; Rawdon C; Murphy J; Cannon M
    Schizophr Bull; 2013 Sep; 39(5):1018-26. PubMed ID: 22927672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Guo JY; Niendam TA; Auther AM; Carrión RE; Cornblatt BA; Ragland JD; Adelsheim S; Calkins R; Sale TG; Taylor SF; McFarlane WR; Carter CS
    Psychol Med; 2020 Oct; 50(13):2230-2239. PubMed ID: 31507256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
    Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
    J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
    de Vos C; Leopold K; Blanke ES; Siebert S; Baumgardt J; Burkhardt E; Bechdolf A
    Psychiatry Res; 2020 Nov; 293():113424. PubMed ID: 32862065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group.
    Simonsen C; Sundet K; Vaskinn A; Birkenaes AB; Engh JA; Faerden A; Jónsdóttir H; Ringen PA; Opjordsmoen S; Melle I; Friis S; Andreassen OA
    Schizophr Bull; 2011 Jan; 37(1):73-83. PubMed ID: 19443616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.